International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report)’s share price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.08 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 3,725 shares changing hands.
International Stem Cell Price Performance
The company’s 50-day moving average is $0.10 and its two-hundred day moving average is $0.08.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Recommended Stories
- Five stocks we like better than International Stem Cell
- Consumer Staples Stocks, Explained
- Oracle Announces Game-Changing News for the AI Industry
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- 3 Fintech Stocks With Good 2021 Prospects
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
